The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).

Shaposhnik Z, Wang X, Trias J, Fraser H, Lusis AJ.

Open source

DOI
10.1194/jlr.m800361-jlr200
Published
2008-11-21
Container
J Lipid Res
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1194/jlr.m800361-jlr200,
  title = {The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).},
  author = {Shaposhnik Z and  Wang X and  Trias J and  Fraser H and  Lusis AJ.},
  year = {2009},
  journal = {J Lipid Res},
  doi = {10.1194/jlr.m800361-jlr200},
  url = {https://doi.org/10.1194/jlr.m800361-jlr200}
}

RIS

TY  - JOUR
TI  - The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).
AU  - Shaposhnik Z
AU  -  Wang X
AU  -  Trias J
AU  -  Fraser H
AU  -  Lusis AJ.
PY  - 2009
JO  - J Lipid Res
DO  - 10.1194/jlr.m800361-jlr200
UR  - https://doi.org/10.1194/jlr.m800361-jlr200
ER  - 

APA

Z, S., X, W., J, T., H, F., & AJ., L. (2009). The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).. J Lipid Res. https://doi.org/10.1194/jlr.m800361-jlr200

Source records